Clinical trial
SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk…
NCT00257543 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00257543 |
|---|---|
| Title | SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease |
| Official title | SALT - Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease |
| Lead sponsor | Emory University, Other |
| Status | Terminated |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Procedure |
| Interventions | Alternative donor bone marrow and cord blood |
| Enrollment | 3 |
| Start date | Jan 1, 2006 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Nov 23, 2005 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: